Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02770014 · FLOW

Participant flow

Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer · Source last updated 2019-11-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Participants who enrolled to the study and had plasma genotyping
    id
    FG000
    title
    Participants With Plasma Genotyping
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        43
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        43
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Plasma Genotyping
  2. milestones
    1. achievements
      1. comment
        A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).
        group Id
        FG000
        num Subjects
        11
      type
      STARTED
    2. achievements
      1. comment
        Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.
        group Id
        FG000
        num Subjects
        6
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        5
      type
      NOT COMPLETED
    title
    EGFR Exon 19 Pos, Treated With Erlotinib
Complete source fields
groups
  1. description
    Participants who enrolled to the study and had plasma genotyping
    id
    FG000
    title
    Participants With Plasma Genotyping
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        43
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        43
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Plasma Genotyping
  2. milestones
    1. achievements
      1. comment
        A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).
        group Id
        FG000
        num Subjects
        11
      type
      STARTED
    2. achievements
      1. comment
        Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.
        group Id
        FG000
        num Subjects
        6
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        5
      type
      NOT COMPLETED
    title
    EGFR Exon 19 Pos, Treated With Erlotinib

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice